IMTX (Immatics NV) Dividends Received


IMTX Immatics NV IMTX
60 GF Score
Price $9.85
GF Value $3.41
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Immatics NV Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

IMTX
60GF Score
Immatics NV IMTX
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Immatics NV (IMTX) Overvalued in 2026?

Based on GuruFocus' analysis, Immatics NV stock appears to be overvalued. The current stock price of $9.85 is trading 188.9% above its estimated GF Value™ of $3.41. GuruFocus considers Immatics NV to be Significantly Overvalued.

Key valuation signals for IMTX:

  • Dividends Received:
  • GF Value™: $3.41 vs. price of $9.85 (188.9% above fair value)
  • GF Score™: 60/100 with 4 warning signs

No single metric tells the full story. See the IMTX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Immatics NV Business Description

Other Exchanges 4A3:Germany
Address Paul-Ehrlich-Strasse 15, Tubingen, BW, DEU, 72076
Immatics NV is a clinical-stage biotechnology company engaged in the research and development of T-cell redirecting immunotherapies for the treatment of cancer patients. The company earns revenue through strategic collaboration agreements with third-party pharmaceutical and biotechnology companies. The company derives its maximum revenue from United States.
60GF Score

Get the complete analysis for IMTX

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.85
Price
$3.41
GF Value